Reactions 1846, p309 - 13 Mar 2021 1 Non-serious case reports The table below provides a list of the drugs associated with non-serious adverse events identified in the scientific literature over the last week.

Non-serious case reports Drug name(s) Adverse event(s) No. of cases

Amoxicillin/clavulanic acid, Cotrimoxazole, Dizziness, Gastrointestinal disorders, Headache, 1 Linezolid, Minocycline Urticaria Anakinra, Canakinumab Exanthema, Hypersensitivity, Injection site 2 reactions Apremilast Photosensitivity 2 Ascorbic acid/folic acid/mecobalamin/pantothenic Fixed drug eruptions 1 acid/riboflavin, Biotin/folic acid/mecobalamin/ pyridoxine/thioctic acid Aspirin, Atorvastatin, Cobalamin, Docosahexaenoic Pruritus 1 acid, Eicosapentaenoic acid, Folic acid, Nebivolol, Olmesartan medoxomil, Omeprazole, Pantoprazole, Pyridoxine, Silodosin, Vitamin K2 Atorvastatin Gynaecomastia 1 Azathioprine Skin disorders 1 Bendamustine Hypersensitivity, Skin disorders 1 Betamethasone, Clobetasol, Dithranol, Drug toxicity, Exanthema, Fixed drug eruptions, 6 Hydroxychloroquine, Methotrexate, Norfloxacin/ Hypopigmentation, Irritant contact dermatitis, tinidazole Mycoses, Oral ulcer, Pityriasis versicolor, Skin disorders, Tinea cruris Bifidobacterium longum/enterococcus faecalis Asthenia, Xerostomia 2 FK23/lactobacillus acidophilus, Flupentixol/ melitracen Clobetasol Skin disorders 1 Cotrimoxazole Erythema, Hypersensitivity, Pruritus 1 Cotrimoxazole Kidney disorders 3 COVID 19 Vaccine Pfizer BioNTech Exanthema 1 COVID 19 Vaccine Pfizer BioNTech, mRNA 1273 Lymphadenopathy 4 Cytarabine, Idarubicin Mucositis 1 Desvenlafaxine Weight gain 1 Dexamethasone Psoriasis 1 DTaP vaccine Injection site pain, Injection site reactions, 5 Lymphadenitis, Malaise, Muscle pain, Oedema, Eculizumab Pruritus 1 Efavirenz, Medroxyprogesterone, Rifampicin Abnormal laboratory parameters 1 Eribulin, Gemcitabine Alopecia, Anorexia, Asthenia, Fatigue, Malaise, 2 Mood disorders Etonogestrel Haemorrhage 1 Everolimus Diarrhoea 1 Hydroxocobalamin, Methylthioninium chloride Urination disorders 1 Hydroxychloroquine Generalised pustular psoriasis 1 Hydroxychloroquine Hyperpigmentation, Skin disorders 1 Hydroxychloroquine Nausea 1 Pain 15 Insulin aspart, Insulin glargine Amyloidosis, Skin disorders 1 Linum usitatissimum Gynaecomastia 1 Measles mumps and rubella virus vaccine Hyperpigmentation 1 Methotrexate Gastrointestinal disorders 1 Methotrexate Nausea 2 Methotrexate, Prednisone Inflammation, Mental disorders 1 Paliperidone Asthenia, Basal ganglia disorders, Endocrine 10 disorders, Injection site pain, Insomnia, Malaise, Mood disorders, Sedation, Weight gain Paracetamol Fixed drug eruptions 2 Perampanel Constipation 1 Progesterone Injection site reactions, Panniculitis 1 Rifampicin, Warfarin Abnormal laboratory parameters, Gingival 1 disorders Rituximab Erythema, Headache, Injection site pain, 6 Urticaria Secukinumab Candidiasis 1 Abnormal laboratory parameters 1 Sorafenib Diarrhoea, Erythrodysaesthesia 1

0114-9954/21/1846-0001/$14.95 Adis © 2021 Springer Nature Switzerland AG. All rights reserved Reactions 13 Mar 2021 No. 1846 2 Single Article

Tacrolimus Alopecia 1 Tacrolimus Candidiasis, Kaposi’s sarcoma 1 Tacrolimus Dermatitis, Granuloma 1 Tofacitinib Lymphopenia, Nausea 2 Topiramate Infantile spasms, Lack of efficacy in critical 1 conditions, Tuberous sclerosis Trimebutine Drug eruptions, Lichenoid eruptions 1 Voriconazole Hypersensitivity 1

Non-serious case reports. Reactions Weekly 10 Mar 2021 803546922

Reactions 13 Mar 2021 No. 1846 0114-9954/21/1846-0002/$14.95 Adis © 2021 Springer Nature Switzerland AG. All rights reserved